TrialEBioMedicine2025

Safety and immunogenicity of the invasive non-typhoidal Salmonella (iNTS)-GMMA vaccine: a first-in-human, randomised, dose escalation trial.

Brama Hanumunthadu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.